Atticus Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $83.3K | Buy |
205
+130
| +173% | +$52.8K | 0.02% | 268 |
|
|
2025
Q1 | $37.5K | Sell |
75
-45
| -38% | -$22.5K | 0.01% | 253 |
|
|
2024
Q4 | $62.6K | Sell |
120
-80
| -40% | -$41.7K | 0.02% | 222 |
|
|
2024
Q3 | $124K | Sell |
200
-62
| -24% | -$38.4K | 0.04% | 153 |
|
|
2024
Q2 | $145K | Sell |
262
-209
| -44% | -$116K | 0.05% | 135 |
|
|
2024
Q1 | $274K | Sell |
471
-130
| -22% | -$75.6K | 0.09% | 104 |
|
|
2023
Q4 | $319K | Buy |
601
+83
| +16% | +$44.1K | 0.11% | 93 |
|
|
2023
Q3 | $262K | Hold |
518
| – | – | 0.1% | 110 |
|
|
2023
Q2 | $270K | Sell |
518
-41
| -7% | -$21.4K | 0.1% | 113 |
|
|
2023
Q1 | $322K | Sell |
559
-36
| -6% | -$20.7K | 0.12% | 97 |
|
|
2022
Q4 | $328K | Buy |
595
+1
| +0.2% | +$550 | 0.13% | 96 |
|
|
2022
Q3 | $322K | Hold |
594
| – | – | 0.16% | 90 |
|
|
2022
Q2 | $322K | Sell |
594
-26
| -4% | -$14.1K | 0.13% | 104 |
|
|
2022
Q1 | $366K | Sell |
620
-99
| -14% | -$58.4K | 0.13% | 102 |
|
|
2021
Q4 | $480K | Sell |
719
-183
| -20% | -$122K | 0.19% | 75 |
|
|
2021
Q3 | $516K | Buy |
902
+123
| +16% | +$70.4K | 0.23% | 57 |
|
|
2021
Q2 | $393K | Buy |
779
+27
| +4% | +$13.6K | 0.17% | 79 |
|
|
2021
Q1 | $343K | Buy |
752
+19
| +3% | +$8.67K | 0.16% | 80 |
|
|
2020
Q4 | $341K | Buy |
733
+177
| +32% | +$82.3K | 0.17% | 76 |
|
|
2020
Q3 | $246K | Buy |
556
+144
| +35% | +$63.7K | 0.15% | 76 |
|
|
2020
Q2 | $149K | Buy |
412
+408
| +10,200% | +$148K | 0.1% | 103 |
|
|
2020
Q1 | $1K | Sell |
4
-2
| -33% | -$500 | ﹤0.01% | 295 |
|
|
2019
Q4 | $2K | Buy |
+6
| New | +$2K | ﹤0.01% | 286 |
|